Taiwan Bio Therapeutics Co., Ltd (TPEX:6892)
Taiwan · Delayed Price · Currency is TWD 27.60
+0.05 (0.18%)
Apr 2, 2026, 2:59 PM CST
Taiwan Bio Therapeutics Market Cap
Taiwan Bio Therapeutics has a market cap or net worth of 2.34 billion as of April 2, 2026. Its market cap has decreased by -26.88% in one year.
Market Cap
2.34B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
27.60
Market Cap Chart
Since May 13, 2022, Taiwan Bio Therapeutics's market cap has increased from 1.93B to 2.34B, an increase of 20.91%. That is a compound annual growth rate of 5.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 2.34B | -3.16% |
| Dec 31, 2025 | 2.41B | -31.88% |
| Dec 31, 2024 | 3.54B | 103.07% |
| Dec 29, 2023 | 1.74B | 7.86% |
| Dec 30, 2022 | 1.62B | -16.32% |
| May 13, 2022 | 1.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sunhawk Vision Biotech | 2.74B |
| 3D Global Biotech | 2.66B |
| G&E Herbal Biotechnology | 2.64B |
| HeXun Biosciences | 2.64B |
| GlycoNex Incorporation | 2.53B |
| Sinew Pharma | 2.36B |
| Gwo Xi Stem Cell Applied Technology Co. , | 2.36B |
| Synbio Tech | 2.21B |